RBC Capital Starts Lexeo Therapeutics (LXEO) at Outperform; 'Solid Team... Commercial Opportunity Just Validated By BIIB'
Tweet Send to a Friend
(Updated - November 28, 2023 6:54 AM EST)
RBC Capital analyst Luca Issi initiates coverage on Lexeo Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
RBC Capital analyst Luca Issi initiates coverage on Lexeo Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
